NRXBF

NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC INC (NRXBF)

About NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC INC (NRXBF)

NurExone Biologic, Inc. is a pharmaceutical company, which engages in the development and commercialization of biological extracellular vesicles-based technology drug platforms. It focuses on the treatment of spinal cord injury, traumatic brain injury, and other brain and neurological indications. The company was founded on June 27, 2011 and is headquartered in Toronto, Canada.

Details

Daily high

Daily low

Price at open

52 Week High

$0.80

52 Week Low

$0.38

Market cap

35.9M

Dividend yield

0.00%

Volume

117

Avg. volume

5,557

P/E ratio

-5.57

NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC INC News